Huayi Quantum announced that it has received over CNY 100,000,000 in a round of funding led by Gaorong Capital on April 22, 2022. The transaction included participation from Orient Pharmaceutical co., ltd., Sequoia China Investment Management LLP, Qiji Chuangtan (Beijing) Investment Management Co., Ltd., Turing Ventures, and Aurisco Pharmaceutical Co.,Ltd.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
22.97 CNY | +1.55% | +2.36% | -11.04% |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-11.04% | 1.29B | |
+40.73% | 739B | |
+32.83% | 598B | |
-6.30% | 353B | |
+15.15% | 318B | |
+4.05% | 285B | |
+15.00% | 240B | |
-5.52% | 206B | |
+6.17% | 164B | |
-0.45% | 162B |
- Stock Market
- Equities
- 605116 Stock
- News Aurisco Pharmaceutical Co.,Ltd.
- Huayi Boao Quantum Technology Co., Ltd. announced that it has received CNY 100 million in funding from Aurisco Pharmaceutical Co.,Ltd., Gaorong Capital, Sequoia China Investment Management LLP, Turing Ventures, Qiji Chuangtan Investment Management Co., Ltd.